Hyperuricemia

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA withdrawal · 2020-07-31
EMA Withdrawn: Zurampic (lesinurad) — Grünenthal GmbH
Zurampic (lesinurad) has been withdrawn from EU marketing by Grünenthal GmbH after regulatory decision.